IFNA1 and COVID-19: In severe COVID-19, profound alterations of the immune system have been described in myeloid cells (20, 21), along with impaired interferon (IFN) responses (22, –24), impaired T cell functions (25, , –28), production of autoantibodies (29), and high circulating levels of inflammatory cytokines (17, 24, 30).